Tandem Diabetes Care (TNDM) Net Cash Flow Growth (3y) (2016 - 2026)
Powered by 
Analysis
Tandem Diabetes Care (TNDM) Net Cash Flow Growth (3y) (2016 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.78 Bn | 175.17 Bn | 7.27 Bn | -9.45% |
| 2 | Intuitive Surgical | 127.04 Bn | 121.82 Bn | 1.96 Bn | -16.59% |
| 3 | Medtronic | 117.04 Bn | 108.22 Bn | 6.34 Bn | -0.80% |
| 4 | Stryker | 103.86 Bn | 100.38 Bn | 4.50 Bn | 60.16% |
| 5 | Boston Scientific | 63.50 Bn | 62.96 Bn | 3.85 Bn | -85.83% |
| 6 | Edwards Lifesciences | 49.74 Bn | 45.49 Bn | 1.35 Bn | 43.26% |
| 7 | Alcon | 32.99 Bn | 31.53 Bn | 1.68 Bn | 1.60% |
| 8 | Dexcom | 32.12 Bn | 30.17 Bn | 830.00 Mn | -26.30% |
| 9 | Steris | 20.69 Bn | 20.21 Bn | 684.20 Mn | 269.22% |
| 10 | Tandem Diabetes Care | 1.27 Bn | 811.05 Mn | 144.78 Mn | -236.36% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -236.36% |
| Mar 31, 2026 | 58.56% |
| Dec 31, 2025 | -27.12% |
| Sep 30, 2025 | 44.60% |
| Jun 30, 2025 | -25.19% |
| Mar 31, 2025 | -37.73% |
| Dec 31, 2024 | 34.56% |
| Sep 30, 2024 | -44.45% |
| Jun 30, 2024 | 19.01% |
| Mar 31, 2024 | -72.67% |
| Dec 31, 2023 | 15.56% |
| Sep 30, 2023 | 18.58% |
| Jun 30, 2023 | -71.78% |
| Mar 31, 2023 | -57.43% |
| Dec 31, 2022 | 112.65% |
| Sep 30, 2022 | 4.54% |
| Jun 30, 2022 | 124.17% |
| Mar 31, 2022 | 163.31% |
| Dec 31, 2021 | -85.15% |
| Sep 30, 2021 | 35.52% |